Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong

Abroad (travel likely)Recruiting

Conditions

COPD Exacerbation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Chinese University of Hong Kong, Hong Kong, New Territories, Hong Kong
Contact: Study coordinator (David S Hui, MD) · dschui@cuhk.edu.hk · 35053133
Contact: Study coordinator (fanny WS Ko, MD) · fannyko@cuhk.edu.hk · 35053133

Study leads

David Hui, MD
Study Director
Chinese University of Hong Kong

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

Angina · Acute Bronchiolitis · Acute Bronchitis

Abroad (travel likely)Recruiting

Caen, France

Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU

Pulmonary Edema · Pneumonia · Atelectasis

Abroad (travel likely)Recruiting

Boston, United States

DUET Versus Standard Interface for Hypercapnic COPD Patients

COPD Exacerbation · Hypercapnia · COPD

Abroad (travel likely)Recruiting

Athens, Greece · Larissa, Greece

Respiratory Strategies in COPD Patients With Persistent Hypercapnia Following Exacerbation

COPD · Hypercapnia · Exacerbation Copd

Abroad (travel likely)Recruiting

Arezzo, Italy · Bolzano, Italy